# Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome

> **NCT01541891** · PHASE2 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 30 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** PRO-148 Ophthalmic Solution
- **DRUG:** Active Comparator: SYSTANE ® Ophthalmic Solution

## Key facts

- **NCT ID:** NCT01541891
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01541891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01541891, "Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01541891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*